229 related articles for article (PubMed ID: 23407292)
1. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
[TBL] [Abstract][Full Text] [Related]
2. Consequences to hearing during the conservative management of vestibular schwannomas.
Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
[TBL] [Abstract][Full Text] [Related]
3. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
Fisher LM; Doherty JK; Lev MH; Slattery WH
Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
[TBL] [Abstract][Full Text] [Related]
4. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
[TBL] [Abstract][Full Text] [Related]
6. Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation.
Phi JH; Kim DG; Chung HT; Lee J; Paek SH; Jung HW
Cancer; 2009 Jan; 115(2):390-8. PubMed ID: 19109818
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
[TBL] [Abstract][Full Text] [Related]
8. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of hearing preservation in untreated vestibular schwannomas.
Sughrue ME; Kane AJ; Kaur R; Barry JJ; Rutkowski MJ; Pitts LH; Cheung SW; Parsa AT
J Neurosurg; 2011 Feb; 114(2):381-5. PubMed ID: 20486891
[TBL] [Abstract][Full Text] [Related]
10. Middle fossa decompression for hearing preservation: a review of institutional results and indications.
Slattery WH; Hoa M; Bonne N; Friedman RA; Schwartz MS; Fisher LM; Brackmann DE
Otol Neurotol; 2011 Aug; 32(6):1017-24. PubMed ID: 21725256
[TBL] [Abstract][Full Text] [Related]
11. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
[TBL] [Abstract][Full Text] [Related]
12. Vestibular schwannoma: role of conservative management.
Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
[TBL] [Abstract][Full Text] [Related]
13. Hearing outcome after gamma knife radiosurgery for vestibular schwannoma: a prospective Belgian clinical study.
Delbrouck C; Hassid S; Choufani G; De Witte O; Devriendt D; Massager N
B-ENT; 2011; 7 Suppl 17():77-84. PubMed ID: 22338378
[TBL] [Abstract][Full Text] [Related]
14. Cochlear implants to treat deafness caused by vestibular schwannomas.
Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
[TBL] [Abstract][Full Text] [Related]
15. [Acoustic neuromas and serviceable hearing: choosing the surgical approach].
Bozorg-Grayeli A; Kalamarides M; Tormin-Borges-Crosara PF; Bouccara D; Rey A; Sterkers O
Neurochirurgie; 2002 Dec; 48(6):479-86. PubMed ID: 12595803
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
[TBL] [Abstract][Full Text] [Related]
18. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
[TBL] [Abstract][Full Text] [Related]
19. Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study.
Delbrouck C; Hassid S; Massager N; Choufani G; David P; Devriendt D; Levivier M
Acta Otorhinolaryngol Belg; 2003; 57(3):197-204. PubMed ID: 14571654
[TBL] [Abstract][Full Text] [Related]
20. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
